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Abstract 
NF-K B plays a pivotal role in cells of the immune system as an inducible transcriptional ctivator. NF-K B regulates the transcription 
of many genes of pro-inflammatory cytokines and cell adhesion molecules, which could be involved in the pathogenesis of 
glomerulonephritis. Using a gel shift assay, we investigated NF-KB DNA-binding activity in glomeruli of WKY rats injected with 
nephrotoxic serum (NTS). Kinetic analysis indicated that the NF-KB DNA-binding activity in glomeruli, composed of p50 subunit 
determined by a supershift assay, increased on day 1 after NTS injection and the maximal activation was observed on day 3 to 5. NF-KB 
activation persisted at least until day 14. Pyrrolidine dithiocarbamate (PDTC), a potent inhibitor of NF-KB activation, inhibited the 
NTS-induced increase of glomerular NF-KB DNA-binding activity, followed by the inhibition of mRNA expression of IL-1/3, MCP-1, 
ICAM-1 and iNOS, which are known to be regulated by NF-KB. PDTC also prevented urinary protein excretion which is a 
pathophysiological parameter for glomerulonephritis. These results suggest that NF-KB activation causes the induction of pro-inflamma- 
tory factors in nephritic glomeruli, which may play significant roles in the pathogenesis of glomerulonephritis. 
Keywords: NF-KB; Pro-inflammatory c tokine; Cell adhesion molecule; Glomerulonephritis; Pyrrolidine dithiocarbamate; Reactive oxygen intermediate 
1. Introduction 
Attention has been focused on the immunological and 
inflammatory processes in the pathogenesis of glomerulo- 
nephritis [1]. During the triggering and subsequent progres- 
sion phases of nephritis, a number of mediators uch as 
reactive oxygen intermediates (ROIs) [2,3], eicosanoids 
[4,5] and inflammatory cytokines [6-10] are secreted in 
glomeruli. Several chemotactic cytokines [11-13] and cell 
adhesion molecules [14-16], which could be involved in 
the infiltration of exogenous inflammatory cells, have been 
reported to be expressed in glomeruli. Chronic inflamma- 
tion in the glomerulus is induced by these inflammatory 
factors. This is accompanied by proliferation of glomerular 
mesangial cells [17] and accumulation of mesangial matrix 
[18], which causes glomerular injury and loss of glomeru- 
lar function. 
* Corresponding author. Fax: +81 6 3002593; e-mail: t- 
sugita@tanabe.co.jp. 
0925-4439/96/$15.00 © 1996 Elsevier Science B.V. All rights reserved 
PII S0925-4439(96)00022-1 
Recent investigations of the regulatory mechanisms of 
gene expression clarify the importance of several transcrip- 
tion factors. In eukaryotes, transcription is regulated by 
particular transcription factors through binding to their 
recognition sequences in a promoter region of correspond- 
ing genes. Nuclear factor-KB (NF-KB), initially identified 
as a protein specifically bound to an enhancer of K im- 
munoglobulin light-chain [19,20], plays a central role in 
the expression of a large number of genes involved in the 
inflammatory and immune responses [21]. The target genes 
for NF-KB include cytokines uch as interleukin-1/3 (IL- 
l/3), IL-6, IL-8, tumor necrosis factor-a (TNF-a), mono- 
cyte chemoattractant protein-1 (MCP-1), cell adhesion 
molecules such as intercellular adhesion molecule-1 
(ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) 
and inducible nitric oxide synthase (iNOS). NF-KB con- 
sists of multi-subunit proteins in Rel family (p50, p52, 
p65(RelA), c-Rel and RelB). In many types of cells, 
p50/p65 heterodimer is mainly detected in the cytoplasm 
as an inactive complex coupled with an inhibitory protein, 
IKB [22]. In response to several stimuli, NF-KB is acti- 
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vated and translocates to the nucleus from cytoplasm. In 
this step, I KB is phosphorylated and dissociates from 
NF-KB. Inhibition of the nuclear translocation by anti- 
oxidants uch as pyrrolidine dithiocarbamate (PDTC) indi- 
cates involvement of oxygen radicals in the NF-KB activa- 
tion pathway [23-27]. Recently, Santriano et al. [28] re- 
ported the activation of NF-KB in cultured murine mesan- 
gial cells, in response to TNF-a and aggregated immuno- 
globulin G, through ROIs-mediating mechanisms. In cul- 
tured rat mesangial cells, NF-KB is also activated by 
TNF-t~ and IL-1/3 and mediates the induction of VCAM-1 
expression [29]. These findings suggest that the ROIs 
and/or NF-KB signal transduction may contribute to the 
induction of inflammatory and pathogenic factors in the 
development of glomerulonephritis. However, there is not 
much information on whether NF-KB can be activated in 
nephritic glomeruli in vivo. 
Granados et al. [30] reported that a small amount of 
nephrotoxic serum (NTS) could induce severe chronic 
proliferative glomerulonephritis with crescent formation in 
WKY rats. An accumulation of CD8 positive cells [31] and 
an enhanced expression of ICAM-1 in glomeruli [32] are 
accompanied by glomerular injury in this model, suggest- 
ing the involvement of some inflammatory processes in- 
duced by cytokines and adhesion molecules. 
In this study, we have investigated the role of ROIs 
and/or NF-KB pathway on the induction of inflammatory 
factors in NTS-induced glomerulonephritis of WKY rats 
using PDTC as a potent inhibitor of NF-KB activation. We 
found that NF-KB activation occurred in glomeruli of 
nephritic rats and that PDTC inhibited NF-KB activation, 
mRNA expression of the NF-KB-regulated genes and pro- 
teinuria. 
2. Materials and methods 
2.1. Induction of  glomerulonephritis 
Glomerular basement membrane (GBM) of WKY rats 
(Charles River Japan) was prepared by the method of 
Krakower and Greenspon [33]. Five albino rabbits were 
immunized subcutaneously with GBM emulsified with 
Freund's complete adjuvant (Difco). Boosters were given 
three times every two weeks using the same immunogen. 
Anti-GBM sera (nephrotoxic sera; NTS) were prepared 
one week after the final booster and were heat-decomple- 
mented. The specificity was confirmed by in vitro 
immunofluorescence on frozen sections of kidney of 
NTS-injected WKY rats using fluorescein isothiocyanate 
(FITC) conjugated anti-rabbit IgG (Jackson). The immuno- 
fluorescence was strongly detected along the GBM. 
Glomerulonephritis was induced in male WKY rats 
(180-220 g body wt.) by the i.v. injection of 0.25 ml/100 
g body wt. of NTS diluted eighty-fold with PBS. Control 
animals were given the same volume of PBS. 
2.2. Preparation of  glomerular nuclear mini-extracts 
At the indicated time after NTS injection, kidney was 
perfused with 20 ml of sterile saline under ether anesthe- 
sia. Glomeruli from one animal were isolated by a frac- 
tional sieving technique and washed twice with 20 ml of 
PBS. Nuclear mini-extracts were prepared from isolated 
glomeruli according to the procedure of Schreiber et al. 
[34] with slight modifications. In brief, glomeruli were 
suspended in 400 lxl of buffer A [10 mM Hepes (pH 7.9), 
10 mM KC1, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM 
dithiothreitol (DTT), and 0.5 mM phenylmethylsulfonyl 
fluoride (PMSF)] and homogenized for 50 strokes in a 
PIERCE B-type glass-homogenizer. The homogenates were 
chilled on ice for 15 min. 25/xl of 10% Nonidet P-40 was 
added and vigorously vortexed for 10 s. The nuclear 
fraction was precipitated by centrifugation at 15000 × g 
for 5 min and suspended in 50-100 /xl of buffer B (20 
mM Hepes (pH 7.9), 0.4 M NaC1, 1 mM EDTA, 1 mM 
EGTA, 1 mM DTT, and 1 mM PMSF). The mixture was 
left on ice for 15 min with frequent agitation. Nuclear 
extracts were prepared by centrifugation at 15 000 × g for 
5 min and stored at -80°C. Protein concentration was 
determined by the DC protein assay reagent (Bio-Rad). 
2.3. Gel shift assay 
DNA-protein binding reactions were performed for 15 
min at room temperature in a mixture (20 ~1) containing 
20 mM Hepes (pH 7.9), 0.3 mM EDTA, 0.2 mM EGTA, 
80 mM NaC1, 2 /xg of poly[dI-dC], 0.1-0.4 ng of 32p_ 
labeled oligonucleotide probe, and nuclear mini-extracts (5
/xg of protein). Where indicated, the reaction was per- 
formed in the presence of non-labeled oligonucleotide 
competitors. Sequences of oligonucleotide were as follows: 
NF-KB, 5'-GTTCGACAGAGGGGACTTTCCGAGAG- 
GCAAC-Y; Octamer binding protein (OCT), 5'-GATTC- 
GATTTGCATGCACAG-3'. The supershift assay was per- 
formed by adding anti-serum against Rel family proteins 
(Santa Cruz). A human recombinant NF-KB p50 homod- 
imer was purchased from Promega. The DNA-protein 
complexes were electrophoresed on 4% polyacrylamide 
gel containing 6.7 mM Tris-HC1 (pH 7.5), 3.3 mM sodium 
acetate, 2.5% glycerol, and 0.1 mM EDTA. Electrophore- 
sis was carried out for 2 hours in a cold room. After 
electrophoresis, the gel was dried and autoradiographed. 
2.4. Northern blotting and RT-PCR 
Total RNA was prepared from glomeruli of two rats by 
the acid guanidinium thiocyanate-phenol-chloroform 
method [35]. 20 p~g of total RNA was electrophoresed in a 
1% agarose-formaldehyde gel and transferred onto a nylon 
filter. The filter was hybridized overnight at 65°C with 
labeled DNA probes, cDNA fragments for murine IL-1/3, 
murine MCP-1, rat ICAM-1 and rat GAPDH were used as 
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probes. After hybridization, the filter was washed and 
antoradiographed. 
RT-PCR was performed by using a Gene Amp RNA 
PCR kit (Perkin-Elmer). First cDNA strand synthesis from 
total RNA (0.5 /zg) was performed by Moloney-murine 
leukemia virus reverse transcriptase with random hexamers 
as a primer, iNOS and GAPDH cDNA was amplified by 
Taq DNA polymerase with the following primers: iNOS, 
5'-GTTTCTGCGCCTTTGCTCAT-3' and 5'-CAATC- 
CACAACTCGCTCCA-3'; GAPDH, 5'-GATGTCATCA- 
TACTTGGCAGG-3' and 5'-ATCGTGGAAGGGCT- 
CATGACC-3'. PCR was performed 30 cycles for iNOS 
and 20 cycles for GAPDH, each cycle consisting of 1 min 
at 95°C, 2 min at 55°C and 2 min at 72°C. PCR products 
were separated on 6% polyacrylamide gels and stained 
with ethidium bromide. 
2.5. Ex vivo glomerular nitrite generation 
Eight hundred glomeruli were suspended in 200 /xl of 
Dulbecco's modified Eagle's medium supplemented with 
10% FCS, 100 U/ml  penicillin and 100 /zg/ml strepto- 
mycin and plated in tissue culture 96-well microplates. 
After 24 h of incubation (37°C, 5% CO2), supernatants 
were collected for nitrite measurements. Nitrite concentra- 
tion was determined by Griess reagent using sodium nitrite 
as a standard [36]. 
2.6. Pharmacological study of pyrrolidine dithiocarbamate 
NTS nephritis was induced by the method as mentioned 
above. Each group contained five rats. PDTC (Sigma) 
freshly dissolved in H20 was administered orally once a 
day from thirty minutes before NTS injection at a dose of 
60 and 200 mg/kg. Control animals received the same 
volume of H20. Urine samples were collected for 24 h on 
days 3 and 8 in metabolic ages and the total amount of 
urinary protein excretion was determined by protein assay 
reagent (Bio-Rad). 
4). Significant activation of NF-KB could be detected at 
least until day 14 (Fig. 1, lane 7), showing the long lasting 
activation of NF-K B in NTS-induced glomerulonephritis. 
To determine whether the complex consists of specifi- 
cally activated NF-KB and NF-KB recognition DNA se- 
quence, we carried out a competition assay (Fig. 2A) and a 
supershift assay (Fig. 2B). The NF-KB DNA-binding ac- 
tivity was competed out with a non-radiolabeled NF-KB 
binding motif in excess (Fig. 2A, lanes 2 and 3), but not by 
a Octamer binding motif (Fig. 2A, lanes 4 and 5). The ns 
band was not competed out by the NF-KB competitor, 
indicating that it may be derived from non-specific DNA- 
binding proteins. As shown in Fig. 2B, the NF-KB-DNA 
complex was supershifted by adding the affinity purified 
IgG against p50 subunits to the reaction mixture of the gel 
shift assay. These results show that NTS induces the 
NF-KB DNA-binding activity in glomeruli, which consists 
of at least a p50 subunit, during the development of 
glomerulonephritis. 
3.2. Effects of PDTC on NF-KB activation and mRNA 
expression of genes regulated by NF-KB 
PDTC possesses an anti-oxidative activity and has been 
used as a potent and specific inhibitor of NF-KB activation 
[23,26]. We analyzed the action of PDTC to clarify the 
involvement of ROIs in the NTS-induced activation of 
NF-KB. A gel shift assay was performed by using nuclear 
extracts prepared from glomeruli on day 3 after PDTC 
treatment. As shown in Fig. 3, the NTS-induced increase 
of NF-KB DNA-binding activity was completely inhibited 
NF-~cB ~- 
. . . . . . . . . .  
3. Resu l ts  
3.1. DNA-binding activity of NF-KB in glomeruli of 
nephritic rats 
ns  >- 
To detect he DNA-binding activity of NF-KB during 
the development of glomerulonephritis, a gel shift assay 
was conducted with nuclear extracts prepared from iso- 
lated glomeruli at the indicated time after NTS injection 
(Fig. 1). The NF-KB DNA-binding activity in normal 
glomeruli was at a very low level (Fig. 1, lane 1). In 
contrast, increased NF-KB DNA-binding activity was de- 
tected in glomeruli of NTS-treated rats (Fig. 1, lanes 2-7). 
Activation of NF-KB was detected on day 1 (Fig. l, lane 
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Fig. 1. Kinetic analysis of NF-KB DNA-binding activity in glomeruli 
treated with NTS. NF-KB activity was determined bya gel shift assay 
with nuclear extracts prepared from normal (lane 1) and nephritic 
glomeruli on day 1 (lane 2), 3 (lane 3), 5 (lane 4), 7 (lane 5), 10 (lane 6) 
and 14 (lane 7). The upper arrow head (NF-KB) indicates the NF-KB- 
probe complexes and lower (F) indicates the free probe, ns, non-specific 
binding. 
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Fig. 2. Identification of NF-KB subunits in nephritic glomeruli. (A) A competition assay for NF-KB DNA-binding activity on day 3 was carried out in the 
absence (lane 1) or presence of NF-KB (lanes 2 and 3) and OCT (lanes 4 and 5) oligonucleotide competitors; 1 ng (lanes 2 and 4) and 10 ng (lanes 3 and 
5) of oligonucleotides were added, respectively. (B) A supershift assay for NF-KB DNA-binding activity. Nuclear extracts were incubated in the absence 
(lane 1) or presence of affinity purified IgGs against p50 (lane 2), p52 (lane 3), p65 (lane 4), c-Rel (lane 5) and RelB (lane 6). 
by PDTC treatment at a dose of 200 mg/kg, suggesting 
possible involvement of ROIs in NF-KB activation in 
glomeruli. 
To determine whether the increased NF-KB DNA-bind- 
ing activity causes the transcriptional induction of the 
genes regulated by NF-KB, expression of several genes 
was analyzed by a Northern blot hybridization. Total RNA 
was prepared from glomeruli on day 3, because the maxi- 
mal NF-KB DNA-binding activity was observed on this 
day (Fig. 1). As shown in Fig. 4, mRNA expression of 
pro-inflammatory c tokines IL-1/3 and MCP-1 were sig- 
nificantly induced by NTS injection and PDTC inhibited 
these expression. Induction of mRNA expression of 
ICAM-1, which is known to be involved in glomerular 
injury in this animal model, was also inhibited by PDTC. 
In contrast, GAPDH mRNA was constitutively expressed 
? 
i 
in glomeruli and the expression was not affected by the 
PDTC treatment. These findings suggest hat NF-KB acti- 
vation through PDTC sensitive-mechanisms ay regulate 
the gene expression of several cytokines and cell adhesion 
molecules in nephritic glomeruli. 
Further analysis of mRNA expression of one of the 
target genes for NF-KB in glomeruli was carried out by 
reverse transcriptase-polymerase chain reaction (RT-PCR). 
We focused on the iNOS gene, because it can be induced 
in cultured mesangial cells [37-39], isolated normal 
glomeruli [40] and glomeruli from other forms of nephritis 
[41,42]. However, it is not well known whether iNOS 
mRNA expression can be induced in glomeruli of rats with 
NTS nephritis. We found that iNOS mRNA expression 
was induced and the induction was completely inhibited by 
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Fig. 3. Effect of PDTC-administration NF-KB activation. A gel shift 
assay was carried out using glomerular nuclear extracts prepared from 




Fig. 4. Northern blot analysis of the NF-K B-regulated genes. Total RNAs 
prepared from normal, nephritic (NTS) and NTS + PDTC-treated (PDTC) 
glomeruli were hybridized with IL-1/3, MCP-I, ICAM-I and GAPDH 
cDNA probes. 
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Fig. 5. Effect of PDTC-administration iNOS expression. (A) Expres- 
sion of iNOS and GAPDH mRNA was determined by RT-PCR with total 
RNA prepared from normal, nephritic (NTS) and NTS + PDTC-treated 
(PDTC) rats on day 3. (B) Nitrite generation was determined in the 
culture supernatants of glomeruli isolated from normal, nephritic and 
PDTC-treated rats on day 3. * * P < 0.01 compared with NTS (Dunnett's 
method). 
an oral administration of PDTC (Fig. 5A). We checked 
subsequent expression of iNOS enzyme activity in 
glomeruli by an ex vivo experiment (Fig. 5B). The nitrite 
concentration in the culture supernatant of glomeruli 
showed that the active iNOS enzyme was produced in 
nephritic glomeruli and NO formation was completely 
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Fig. 6. Effect of PDTC-administration on urinary protein excretion. 
Urinary protein excretion for 24 h on day 3 and day 8 is shown. Each bar 
shows normal (O), NTS only (11), PDTC treatment at doses of 60 
mg/kg  (grey bars) and 200 mg/kg  (cross-hatched bars), respectively. 
Data are meanzkSE of five rats. * * P <0.01 compared with control 
(Dunnett's method). 
3.3. Effect of PDTC on urinary protein excretion 
Finally we examined the effect of PDTC on urinary 
protein excretion which is an important pathophysiological 
parameter for glomerulonephritis. All animals injected with 
NTS showed significant excretion of urinary proteins from 
day 3 to day 8 (Fig. 6). In groups orally treated with 
PDTC, urinary protein excretion was inhibited in a dose 
dependent manner. PDTC, at a dose of 200 mg/kg, inhib- 
ited proteinuria on day 3 and day 8 by 99% and 79%, 
respectively. On day 10, creatinine clearance, which re- 
flects the glomerular function, of the group treated with 
200 mg/kg PDTC retained at the normal evel (nephritis; 
1761.6 _+ 250.9 ml vs PDTC-treated; 2704.4_ 220.3 ml). 
Furthermore, other parameters such as serum cholesterol 
and serum urea nitrogen were also improved by the PDTC 
treatment (data not shown). 
4. Discussion 
NF-KB is a transcription factor that is one of the most 
extensively exploited factors in cells of the immune system 
[21]. A recent study of mice deficient in the NF-KB p50 
subunit demonstrated the important functions of NF-K B in 
immune responses [43]. A wide variety of genes, in which 
NF-KB participates as an inducible transcriptional ctiva- 
tor, have been shown to be expressed and involved in the 
pathogenesis of several inflammatory diseases. In glomer- 
ulonephritis, several pro-inflammatory c tokines and cell 
adhesion molecules are reported to play pathogenic roles. 
In fact, IL-1 receptor antagonist [44] and antibodies against 
IL-8 [13] and ICAM-1 [32,45] prevented glomerular injury. 
Since NF-KB may play significant roles in the regulation 
of these genes, we have analyzed the kinetics of NF-K B 
activation in glomeruli of nephritic rats. We found that the 
activation of NF-KB occurred in the course of the develop- 
ment of NTS-induced nephritis. It is noteworthy that acti- 
vation was observed in the progression phase as well as in 
the initiation phase of glomerulonephritis (Fig. 1). 
NF-K B consists of hetero- or homodimeric forms of Rel 
family proteins (p50, p52, p65, c-Rel and RelB). These 
proteins hare high sequence homology over the 300 amino 
acid (rel homology region) and the composition of dimer 
determines the DNA-binding specificity of target se- 
quences [46]. As shown in Fig. 2, only the p50 subunit was 
detected in glomerular NF-KB complex using a consensus 
NF-KB binding site as a probe. The pS0-containing 
glomerular NF-KB complex co-migrated with the human 
recombinant p50 homodimer (data not shown). And this 
band migrated faster than the p65-containing NF-KB com- 
plex of Jurkat T cells in a gel shift assay (data not shown). 
These results suggested that the complex might be com- 
posed of p50 homodimer. However, this could not exclude 
the possibility of the usage of other subunits because other 
subunits dimerized with p50 may not be recognized by the 
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corresponding antisera due to some modifications such as 
phosphorylation [47]. 
However, it is not clear which types of cells are the 
source of NF-KB activity. In NTS nephritis of WKY rats, 
increased infiltration of CD8 positive cells and ED-1 posi- 
tive cells has been reported [31]. The peak influx of CD8 
positive cells in glomeruli was observed on day 3 and that 
of ED-l positive cells on day 6 to 11. Maximal activation 
of NF-KB on day 3 suggests that this event on day l to 5 
may occur in the CD8-positive cells. The persistent NF-KB 
DNA-binding activity on day 7 to 14 might be partially 
due to ED-1 positive cells. Resident glomerular cells stim- 
ulated with the pro-inflammatory c tokines released by 
infiltrating cells may be another source of the NF-KB 
activity. Further immunohistochemical analysis is needed 
to clarify the localization and character of the NF-KB 
expressing cells. 
We have used PDTC as an inhibitor of NF-xB activa- 
tion. PDTC is reported to have at least two chemical 
properties [26]. One is scavenging activity for radicals. 
Another is chelating activity for heavy metal ions which 
will be needed to catalyze decomposition of H20 2 into 
hydroxyl radicals. These actions may be contribute to the 
inhibitory effect for NF-KB activation. However, precise 
mechanism of inhibitory activity of PDTC is not clear. 
Several ines of evidence indicate that ROIs may medi- 
ate the glomerular injury [2,3]. Infiltrating inflammatory 
cells such as monocytes/macrophages and leukocytes have 
been shown to produce large amounts of ROIs [48]. En- 
dogenous glomerular cells are also able to release ROIs 
that may enhance the inflammatory response [49]. Re- 
cently, ROls have been reported to act as a second messen- 
gers in the NF-KB activation pathway in many cells 
including glomerular mesangial cells [28]. In this study, we 
observed the activation of NF-KB in nephritic glomeruli. 
From these findings, we propose that ROIs might induce 
glomerular injury through NF-KB activation as well as 
through cytotoxic effects. In fact, several genes that could 
be regulated by NF-KB were transcriptionaly induced dur- 
ing the development of glomerulonephritis. In NTS-in- 
duced nephritis of WKY rats, enhanced expression of 
ICAM-1 in glomeruli plays a pathogenic role in glomeru- 
lar injury [32]. ICAM-1 expression had the same kinetics 
as the NF-KB activation as presented here and was inhib- 
ited by PDTC administration. In addition, mRNA expres- 
sion of other target genes for NF-KB such as IL- l f l  and 
interferon-y are induced in glomeruli and their peak ex- 
pression was also observed on day 3 (Fujinaka, H., per- 
sonal communication). This evidence strongly suggests 
that ROIs and/or NF-K B pathways could contribute to the 
transcriptional activation of the genes encoding pro-in- 
flammatory factors, which may play pathophysiological 
roles in glomerulonephritis. 
Nitric oxide (NO) has been identified as a pleiotropic 
intercellular messenger regulating a variety of diverse cel- 
lular functions. However, a large amount of NO might 
contribute to the pathophysiological lterations in some 
inflammatory diseases. In immune complex glomerulo- 
nephritis, iNOS mRNA expression is induced in glomeruli 
[41]. The pathophysiological ro e of NO is determined by 
using NOS inhibitors. ANOS inhibitor, Nr-monomethyl - 
L-arginine, inhibited the proteinuria of lupus nephritis prone 
mouse MRL-lpr/lpr [50]. Here, we reported for the first 
time that iNOS mRNA expression was induced in glomeruli 
of WKY rats with NTS nephritis and the induction was 
inhibited by PDTC administration. These results support 
the observation that PDTC inhibits IL-1/3-induced iNOS 
mRNA expression in cultured murine mesangial cells [38]. 
The p50 homodimer was able to bind to NF-KB binding 
site in the murine iNOS promoter [51,52], which further 
define the roles of ROIs and/or NF-KB (probably the p50 
homodimer) pathway in the induction of iNOS gene ex- 
pression in nephritic glomeruli. These results suggest hat 
prevention of NF-KB activation may lead to the inhibition 
of inflammatory process caused by nephritogenic stimuli 
such as overproduction of NO [53]. 
In summary, we have demonstrated the NF-K B activa- 
tion in vivo and the possible involvement of ROIs and/or 
NF-KB pathway in the induction of inflammatory factors 
in nephritic glomeruli. Anti-nephritic action of PDTC raises 
the possibility of a novel therapeutic approach of glomer- 
ulonephritis by the intervention of NF-KB activation. Fur- 
ther analysis by using anti-sense oligonucleotides of NF-K B 
subunits or double-strand oligonucleotide decoys contain- 
ing NF-KB binding sites will be useful in confirming this 
possibility. 
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